References
- Stupp R, Mason WP, van den Bent MJ, et al.;European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 2005;352:987–96.
- Gorlia T, van den Bent MJ, Hegi ME, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 2008;9:29–38.
- Parks CJ, Law J, Davis CH, Hall G. Glioblastoma: can we predict a patient's survival?Br J Neurosurg 2009;23:480 (abstract).
- Hanlon P, Walsh D, Buchanan D, et al. Chasing the Scottish Effect: Why Scotland Needs a step-Change in Health if it is to Catch Up with the Rest of Europe. Glasgow: Public Health Institute of Scotland; 2001.
- Leon DA, Morton S, Cannegieter S, McKee M. Understanding the Health of Scotland's Population in an International Context: A Review of Current Approaches, Knowledge and Recommendations for New Research Direction. Glasgow: Public Health Institute of Scotland; 2003.
- Carstairs V, Morris R. Deprivation: explaining differences in mortality between Scotland and England and Wales. BMJ 1989; 299: 886–889.
- News.bbc.co.uk. 2002 [updated 18 Feb 2002; cited 30 April 2013]. Available from: http://news.bbc.co.uk/1/hi/uk/1826411.stm
- News.bbc.co.uk. 2003 [updated 27 Feb 2003; cited 30 April 2013]. Available from: http://news.bbc.co.uk/go/pr/fr/-/1/hi/scotland/2804895.stm
- The Centre for Social Justice. Breakthrough Glasgow: Ending the Costs of Social Breakdown. London: Centre for Social Justice, 2008.
- Isdscotlandarchive.scot.nhs.uk. Information and Statistics Scotland; 2011 [updated 11 Apr 2011; cited 30 April 2013]. Available from: http://www.isdscotland.org/isd/3211.html
- Cairstairs V, Morris R. Deprivation, mortality and resource allocation. Community Med 1989;11:364–72.
- Stummer W, Reulen HJ, Meiner T, et al.; ALA-Glioma Study Group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62: 564–76.
- Stummer W, Pichlmeier U, Meinel T, et al.; ALA-Glioma Study Group. Fluoresecence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.
- Thon N, Eigenbrod S, Grasbon-Frodl EM, et al. Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. J Neurol Neurosurg Psychiatry 2011;82:441–6.
- Woods LM, Rachet B, Coleman MP. Origins of socioeconomic inequalities in cancer survival: a review. Ann Oncol 2006;17:5–19.
- Kogevinas M, Porta M. Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ 1997;138:177–206.